Goldenrod Therapeutics, Inc. funding
Goldenrod Therapeutics, Inc., a biotechnology company based in Houston, TX (founded 2023), filed a Form D with the SEC on June 3, 2026 and reported $3.2M raised of a $6.5M offering.
Amount raised$3.2M
Offering size$6.5M
Filed with the SECJune 3, 2026
First saleMay 26, 2026
IndustryBiotechnology
SecuritiesEquity
LocationHouston, TX
Founded2023
Entity typeCorporation
Investors so far2
Minimum investment$100K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 3
Other health care rounds in Texas
OncoNano Medicine, Inc.$10.1M · Oct 8BiotechnologySolaris Endovascular Inc.$5M · Oct 1BiotechnologyTransformer TX Holdings, LLC$4.1M · Nov 9Hospitals and PhysiciansTeos Health, LLC$3.1M · Oct 30Other Health CareCerenome, Inc.$3M · Sep 18Other Health CareFibroBiologics, Inc.$1.2M · Oct 13PharmaceuticalsPressio, Inc.$544K · Oct 6Other Health CareIctero Medical, Inc.$344K · Nov 5Other Health Care